Sight Sciences, Inc.

Sight Sciences, Inc. (SGHT) priced its initial public offering on Jul 15, 2021 at $24.00 per share, within its $23.00–$24.00 range, raising $240M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.09B. Morgan Stanley was lead-left underwriter, joined by BofA Securities, Citigroup and Piper Sandler. Latham & Watkins advised the company and Davis, Polk & Wardwell advised the underwriters.

Sight Sciences, Inc. develops and commercializes proprietary devices for ophthalmology and optometry that target the underlying causes of common eye diseases. Its products are intended to restore natural eye function and are sold to ophthalmologists and optometrists.

Status

IPO

Ticker

SGHT

Exchange

Nasdaq Global Select

Priced

Jul 15, 2021

IPO price

$24.00

Price range

$23.00–$24.00

Raised

$240M

Market cap at IPO price

$1.09B

First filed

Jun 23, 2021

Underwriters

Morgan Stanley, BofA Securities, Citigroup and Piper Sandler

Company counsel

Latham & Watkins

Underwriters' counsel

Davis, Polk & Wardwell

Sector

Healthcare

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.